As of April 2024 Spectrum Pharmaceuticals has a market cap of $0.21 Billion. This makes Spectrum Pharmaceuticals the world's 6880th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $0.21 B | 0% |
2023 | $0.21 B | 182.32% |
2022 | $74.88 M | -64.04% |
2021 | $0.20 B | -58.15% |
2020 | $0.49 B | 20.66% |
2019 | $0.41 B | -57.36% |
2018 | $0.96 B | -49.3% |
2017 | $1.90 B | 434.52% |
2016 | $0.35 B | -13.26% |
2015 | $0.41 B | -10.01% |
2014 | $0.45 B | -19.42% |
2013 | $0.56 B | -15.51% |
2012 | $0.67 B | -20.05% |
2011 | $0.83 B | 137.57% |
2010 | $0.35 B | 62.74% |
2009 | $0.21 B | 358.37% |
2008 | $47.39 M | -44.22% |
2007 | $84.95 M | -39.08% |
2006 | $0.13 B | 40.27% |
2005 | $99.41 M | 0.69% |
2004 | $98.73 M | 45.68% |
2003 | $67.77 M | 1281.33% |
2002 | $4.9 M | -94.36% |
2001 | $87.02 M |
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $357.92 B | 169,208.84% | ๐บ๐ธ USA |
Novartis NVS | $200.67 B | 94,824.84% | ๐จ๐ญ Switzerland |
Pfizer PFE | $148.75 B | 70,265.44% | ๐บ๐ธ USA |
Abbott Laboratories ABT | $185.47 B | 87,634.35% | ๐บ๐ธ USA |
Biogen BIIB | $29.36 B | 13,788.84% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | $99.02 B | 46,742.91% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | $83.47 B | 39,387.64% | ๐ฌ๐ง UK |
Seagen
SGEN | $43.15 B | 20,313.48% | ๐บ๐ธ USA |
Curis CRIS | $87.05 M | -58.82% | ๐บ๐ธ USA |
Teva Pharmaceutical Industries TEVA | $14.73 B | 6,870.39% | ๐ฎ๐ฑ Israel |